These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21808898)

  • 41. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN; Olsen JA
    Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).
    Thuppal S; Markwell S; Crabtree T; Hazelrigg S
    Qual Life Res; 2019 Jul; 28(7):1885-1892. PubMed ID: 30707368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.
    Hoshi D; Tanaka E; Igarashi A; Inoue E; Kobayashi A; Sugimoto N; Shidara K; Sato E; Seto Y; Nakajima A; Momohara S; Taniguchi A; Tsutani K; Yamanaka H
    Mod Rheumatol; 2016; 26(1):40-5. PubMed ID: 26052801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of health-related quality of life and functional recovery measurement tools in out-of-hospital cardiac arrest survivors.
    Andrew E; Nehme Z; Bernard S; Smith K
    Resuscitation; 2016 Oct; 107():57-64. PubMed ID: 27521474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain.
    Søgaard R; Christensen FB; Videbaek TS; Bünger C; Christiansen T
    Value Health; 2009 Jun; 12(4):606-12. PubMed ID: 19900258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health-Related Quality of Life and Functional Ability of Patients with Rheumatoid Arthritis: A Study from a Tertiary Care Hospital in Thailand.
    Munchey R; Pongmesa T
    Value Health Reg Issues; 2018 May; 15():76-81. PubMed ID: 29474183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimating the SF-6D value set for a population-based sample of Brazilians.
    Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unchained melody: revisiting the estimation of SF-6D values.
    Craig BM
    Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.
    Carreño A; Fernández I; Badia X; Varela C; Roset M
    Value Health; 2011 Jan; 14(1):192-200. PubMed ID: 21211502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
    J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.
    Bharmal M; Thomas J
    Value Health; 2006; 9(4):262-71. PubMed ID: 16903996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brazilian urban population norms derived from the health-related quality of life SF-6D.
    Ciconelli RM; Ferraz MB; Kowalski S; Pinheiro Gda R; Sato EI
    Qual Life Res; 2015 Oct; 24(10):2559-64. PubMed ID: 25894065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.
    Tsuchiya A; Brazier J; Roberts J
    J Health Econ; 2006 Mar; 25(2):334-46. PubMed ID: 16271783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.
    Kularatna S; Byrnes J; Chan YK; Ski CF; Carrington M; Thompson D; Stewart S; Scuffham PA
    Qual Life Res; 2017 Dec; 26(12):3399-3408. PubMed ID: 28766084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
    Boonen A; van der Heijde D; Landewé R; van Tubergen A; Mielants H; Dougados M; van der Linden S
    Ann Rheum Dis; 2007 Jun; 66(6):771-7. PubMed ID: 17213254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.
    Kwakkenbos L; Fransen J; Vonk MC; Becker ES; Jeurissen M; van den Hoogen FH; van den Ende CH
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):50-6. PubMed ID: 23910610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health Utilities for Multiple Sclerosis.
    Hawton A; Green C
    Value Health; 2016 Jun; 19(4):460-8. PubMed ID: 27325338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.